APA (7th ed.) Citation

Fernández de Retana Alda, S., Fatar, M., & Grudzenski-Theis, S. (2017). Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease. Neurobiology of aging, 60, . https://doi.org/10.1016/j.neurobiolaging.2017.08.028

Chicago Style (17th ed.) Citation

Fernández de Retana Alda, Sofía, Marc Fatar, and Saskia Grudzenski-Theis. "Intravenous Treatment with Human Recombinant ApoA-I Milano Reduces Beta Amyloid Cerebral Deposition in the APP23-transgenic Mouse Model of Alzheimer's Disease." Neurobiology of Aging 60 (2017). https://doi.org/10.1016/j.neurobiolaging.2017.08.028.

MLA (9th ed.) Citation

Fernández de Retana Alda, Sofía, et al. "Intravenous Treatment with Human Recombinant ApoA-I Milano Reduces Beta Amyloid Cerebral Deposition in the APP23-transgenic Mouse Model of Alzheimer's Disease." Neurobiology of Aging, vol. 60, 2017, https://doi.org/10.1016/j.neurobiolaging.2017.08.028.